Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still’s Disease

Figure 4

Mean daily corticosteroid dosage (prednisone or equivalent in mg/day) recorded at the start of canakinumab treatment and at the subsequent follow-up visits. Horizontal lines and overlying values describe pairwise comparisons between different time points.